Related Experiment Video
Updated: May 16, 2026

Screening and Identification of Small Peptides Targeting Fibroblast Growth Factor Receptor2 using a Phage Display Peptide Library
Published on: September 30, 2019
Combination of phage display and molecular grafting generates highly specific tumor-targeting miniproteins
Frederic Zoller1, Annette Markert, Philippe Barthe
1DKFZ, Klinische Kooperationseinheit Nuklearmedizin, Heidelberg, Germany.
Abstract:
Frankenstein's peptide: the grafting of the binding domain from miniprotein Min-23 into the sunflower trypsin inhibitor (SFTI-I) peptide scaffold preserved its in vitro and in vivo binding specificity and proteolytic stability. The combination of these peptides was shown to be tumor-specific with a good binding affinity for delta-like ligand 4 (Dll4) protein. The use of SFTI-I as a peptide scaffold is ideal for hit-to-lead development.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Conservative Site-specific Recombination and Phase Variation
The recognition sites for Cre recombinase called LoxP...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

